Scotia Capital’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$8.46M Buy
99,293
+7,461
+8% +$665K 0.03% 232
2025
Q4
$7.26M Buy
91,832
+19,690
+27% +$1.54M 0.03% 248
2025
Q3
$5.77M Buy
72,142
+3,180
+5% +$271K 0.02% 274
2025
Q2
$6.27M Buy
68,962
+4,980
+8% +$455K 0.03% 251
2025
Q1
$6M Buy
63,982
+249
+0.4% +$22.3K 0.03% 236
2024
Q4
$5.79M Buy
63,733
+2,028
+3% +$194K 0.03% 240
2024
Q3
$6.41M Sell
61,705
-52
-0.1% -$5.3K 0.03% 223
2024
Q2
$5.99M Sell
61,757
-2,526
-4% -$233K 0.04% 226
2024
Q1
$5.79M Sell
64,283
-2,029
-3% -$172K 0.03% 234
2023
Q4
$5.29M Buy
66,312
+131
+0.2% +$9.85K 0.03% 229
2023
Q3
$4.71M Sell
66,181
-1,175
-2% -$87.9K 0.03% 236
2023
Q2
$5.19M Sell
67,356
-2,243
-3% -$174K 0.04% 222
2023
Q1
$5.23M Sell
69,599
-22,810
-25% -$1.7M 0.04% 215
2022
Q4
$7.28M Sell
92,409
-1,647
-2% -$123K 0.06% 182
2022
Q3
$6.61M Sell
94,056
-856
-0.9% -$67.1K 0.05% 186
2022
Q2
$7.61M Sell
94,912
-2,081
-2% -$163K 0.06% 181
2022
Q1
$7.36M Buy
96,993
+1,589
+2% +$126K 0.05% 200
2021
Q4
$8.14M Buy
95,404
+3,740
+4% +$292K 0.05% 191
2021
Q3
$6.93M Buy
91,664
+2,877
+3% +$228K 0.05% 210
2021
Q2
$7.22M Buy
88,787
+2,917
+3% +$239K 0.05% 198
2021
Q1
$6.77M Buy
85,870
+4,511
+6% +$354K 0.05% 195
2020
Q4
$6.96M Sell
81,359
-598
-0.7% -$49.4K 0.06% 168
2020
Q3
$6.32M Sell
81,957
-262
-0.3% -$20K 0.07% 164
2020
Q2
$6.03M Sell
82,219
-15,692
-16% -$1.11M 0.08% 137
2020
Q1
$6.5M Buy
97,911
+4,500
+5% +$317K 0.09% 129
2019
Q4
$6.43M Buy
93,411
+3,523
+4% +$240K 0.07% 153
2019
Q3
$6.61M Buy
89,888
+2,062
+2% +$150K 0.08% 144
2019
Q2
$6.29M Buy
87,826
+3,892
+5% +$276K 0.08% 143
2019
Q1
$5.75M Buy
83,934
+9,552
+13% +$617K 0.07% 151
2018
Q4
$4.43M Buy
74,382
+5,151
+7% +$322K 0.07% 170
2018
Q3
$4.63M Buy
69,231
+29,430
+74% +$1.96M 0.06% 188
2018
Q2
$2.83M Buy
39,801
+1,121
+3% +$73.3K 0.04% 233
2018
Q1
$2.77M Buy
38,680
+1,040
+3% +$74.8K 0.04% 243
2017
Q4
$2.84M Buy
37,640
+5,129
+16% +$375K 0.04% 240
2017
Q3
$2.37M Buy
32,511
+3,949
+14% +$285K 0.03% 259
2017
Q2
$2.12M Buy
28,562
+1,016
+4% +$75.4K 0.04% 243
2017
Q1
$2.02M Buy
27,546
+888
+3% +$62.2K 0.03% 257
2016
Q4
$1.75M Buy
26,658
+172
+0.6% +$11.8K 0.03% 322
2016
Q3
$1.96M Sell
26,486
-259
-1% -$19.1K 0.04% 302
2016
Q2
$1.96M Buy
26,745
+191
+0.7% +$13.6K 0.04% 280
2016
Q1
$1.88M Buy
26,554
+1,947
+8% +$130K 0.04% 253
2015
Q4
$1.54M Hold
24,607
0.04% 323
2015
Q3
$1.56M Sell
24,607
-1,918
-7% -$125K 0.04% 305
2015
Q2
$1.73M Buy
26,525
+2,516
+10% +$171K 0.03% 305
2015
Q1
$1.67M Sell
24,009
-9,683
-29% -$669K 0.04% 246
2014
Q4
$2.33M Sell
33,692
-3,263
-9% -$220K 0.06% 195
2014
Q3
$2.41M Buy
36,955
+4,221
+13% +$278K 0.05% 197
2014
Q2
$2.23M Buy
32,734
+2,882
+10% +$193K 0.05% 200
2014
Q1
$1.94M Buy
29,852
+1,232
+4% +$77.6K 0.04% 201
2013
Q4
$1.87M Sell
28,620
-1,902
-6% -$122K 0.04% 201
2013
Q3
$1.81M Buy
30,522
+8,501
+39% +$504K 0.05% 189
2013
Q2
$1.26M Buy
+22,021
New +$1.31M 0.05% 198

Other funds holding CL

Scotia Capital's CL Position: Q1 2026 in Review

Scotia Capital increased its Colgate-Palmolive (CL) stake by 8.1% in Q1 2026, buying an estimated $665K and bringing the position to 99,293 shares worth $8.46M. The position accounts for 0.03% of the portfolio, ranked #232.

Scotia Capital first reported a position in CL in Q2 2013 and has held it in 52 quarters since. 1,946 funds tracked by Wall St. Rank hold CL as of Q1 2026.

  • Scotia Capital held 99,293 shares of Colgate-Palmolive worth $8.46M as of Q1 2026.
  • Scotia Capital bought 7,461 Colgate-Palmolive shares in Q1 2026, an estimated $665K.
  • Colgate-Palmolive made up 0.03% of Scotia Capital's portfolio in Q1 2026, its #232 holding.
  • Scotia Capital first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 52 quarters since.
  • 1,946 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2026.

Based on Scotia Capital's 13F filing for Q1 2026, filed 13 May 2026.